Porcilis M Hyo, suspension for injection

Nchi: Ayalandi

Lugha: Kiingereza

Chanzo: HPRA (Health Products Regulatory Authority)

Viambatanisho vya kazi:

Mycoplasma hyopneumoniae strain 11 inactivated whole cell concentrate

Inapatikana kutoka:

Intervet Ireland Limited

ATC kanuni:

QI09AB13

INN (Jina la Kimataifa):

Mycoplasma hyopneumoniae strain 11 inactivated whole cell concentrate

Kipimo:

.

Dawa fomu:

Suspension for injection

Dawa ya aina:

POM: Prescription Only Medicine as defined in relevant national legislation

Kundi la matibabu:

Pigs

Eneo la matibabu:

mycoplasma

Matibabu dalili:

Immunological - Inactivated Vaccine

Idhini hali ya:

Authorised

Idhini ya tarehe:

2005-12-21

Tabia za bidhaa

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Porcilis M Hyo, suspension for injection.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Per dose of 2 ml
ACTIVE SUBSTANCE
Inactivated whole cell concentrate of_ Mycoplasma hyopneumoniae_
strain 11:
7.0 log
2
Ab titre
* Mean antibody titre (Ab) obtained after inoculation of mice with a
1/20 pig dose.
ADJUVANT
150 mg dl-
-tocopheryl acetate
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection; white or nearly white.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pig (finishing pigs).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For finishing pigs:
For the active immunisation of pigs to reduce pulmonary lesions due to
infection by_ Mycoplasma hyopneumoniae._
Onset of immunity: 2 weeks after the second injection
Duration of immunity: at least 20 weeks after the second injection.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_3_
_0_
_/_
_0_
_3_
_/_
_2_
_0_
_1_
_2_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_2_
_2_
_3_
_0_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Vaccinate only healthy animals.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
In case of accidental self-injection, seek medical advice immediately
and show the package insert or label to the
physician.
4.6 ADVERSE REACTIONS (FREQ